Which ETFs hold Centessa Pharmaceuticals plc?
260 is held by 2 of the 504 ETFs we cover. The heaviest allocation is IBB at 0.3%; among the largest funds, ONEQ holds 0.0%. The median weight across all funds holding it is 0.0%.
- Covered ETFs Holding It
- 2
- Heaviest Allocation
- 0.25%in IBB
- Median Weight
- 0.01%across funds that hold it
Funds Holding 260(2)
| ETF | |||||||
|---|---|---|---|---|---|---|---|
| IBBiShares Biotechnology ETF | 0.25% | 0.44% | $9.3B | 0.21% | +17.3% | +51.0% | +3.1% |
| ONEQFidelity Nasdaq Composite Index ETF | 0.01% | 0.21% | $10.8B | 0.51% | +15.4% | +26.6% | +13.6% |
Expense = net expense ratio from the fund's latest SEC prospectus filing. YTD/1Y/5Y are trailing total returns including dividends (5Y annualized, as of 2026-08-07). Past performance does not predict future results. Sort by any column.
Frequently Asked Questions
Which ETF has the most 260 exposure?
IBB has the heaviest 260 allocation of the ETFs we cover, at 0.25% of its portfolio, based on the fund's latest SEC-reported holdings.
How many ETFs hold 260?
2 of the 504 ETFs we cover hold Centessa Pharmaceuticals plc (260). The median weight across those funds is 0.01%.
What is the cheapest ETF that holds 260?
ONEQ has the lowest expense ratio among covered ETFs holding 260, at 0.21% per year.
What is the largest ETF that holds 260?
ONEQ (Fidelity Nasdaq Composite Index ETF) is the largest covered ETF holding 260, with $10.8B in assets and a 0.01% position.
Keep Exploring
Look up another stock or compare two of these ETFs to see how much they overlap beyond 260.